Pier Vincenzo Plazzi

Author PubWeight™ 18.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies. J Med Chem 2004 2.05
2 Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. J Med Chem 2003 1.50
3 5-benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity. Bioorg Med Chem Lett 2006 1.02
4 Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring. ChemMedChem 2006 1.01
5 Aryl azoles with neuroprotective activity--parallel synthesis and attempts at target identification. Bioorg Med Chem 2007 0.98
6 Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists. Bioorg Med Chem 2004 0.85
7 Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models. J Med Chem 2005 0.83
8 Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series. Bioorg Med Chem 2005 0.81
9 Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists. Bioorg Med Chem 2005 0.80
10 Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity. J Med Chem 2004 0.79
11 Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation. J Med Chem 2003 0.78
12 Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold. Bioorg Med Chem Lett 2006 0.78
13 Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. Chem Biodivers 2008 0.78
14 Antioxidant and cytoprotective activity of indole derivatives related to melatonin. Adv Exp Med Biol 2003 0.77
15 Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. Bioorg Med Chem 2008 0.77
16 Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitors. Chem Biodivers 2005 0.77
17 The role of HB-donor groups in the heterocyclic polar fragment of H3-antagonists. I. Synthesis and biological assays. Farmaco 2003 0.76
18 5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line. Eur J Med Chem 2009 0.76
19 Imidazole H3-antagonists: relationship between structure and ex vivo binding to rat brain H3-receptors. Eur J Pharm Sci 2004 0.76
20 Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity. J Pineal Res 2006 0.75
21 Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group. Drug Des Discov 2003 0.75
22 Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities. J Pineal Res 2004 0.75